Paul Talmo - 23 Feb 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Chief Technology Officer
Signature: /s/ Megan Smeykal, Attorney-in-fact
Issuer symbol: TELA
Transactions as of: 23 Feb 2024
Net transactions value: -$25,636
Form type: 4
Filing time: 27 Feb 2024, 16:35:41 UTC
Previous filing: 04 Apr 2023
Next filing: 02 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Award	$0	+16,700	+30%	$0.000000	72,676	23 Feb 2024	Direct	F1
transaction	TELA	Common Stock	Tax liability	$18,219	-2,577	-3.5%	$7.07	70,099	23 Feb 2024	Direct	F2
transaction	TELA	Common Stock	Tax liability	$7,416	-1,049	-1.5%	$7.07	69,050	24 Feb 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TELA	Stock Option (Right to Buy)	Award	$0	+24,400		$0.000000	24,400	23 Feb 2024	Common Stock	24,400	$7.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2	Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3	The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.